Trial Profile
A pilot study of the effect of rotigotine on sleep through actigraphic recording in Parkinson's disease patients with self‐reported sleep complaints.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Aug 2015
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Pharmacodynamics
- 14 Aug 2015 New trial record
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.